Merck Millipore Webinars

Upcoming and On-Demand


View upcoming and on-demand webinars to learn advanced research techniques, valuable tips and advice from leaders in their fields of scientific research.

On-Demand Webinars by Topic Area:

Upcoming Webinars

Take part in our complimentary, live webinars, where you’ll interact with experts who are breaking ground in the industrial microbiology, life science research, IVD/OEM, pharmaceutical and biopharmaceautical industries. You’ll learn about the newest tools and technologies while gathering valuable tips and troubleshooting strategies for the applications most relevant to your processes.

Find an upcoming webinar below and register today!


Biopharmaceutical Manufacturing and Small Molecule Pharmaceuticals

Demystifying Bioreactor Contamination Risks

  • Presenter: Christine Wright, Ph.D., Senior Research Scientist, Merck Millipore
  • Date: Thursday, April 2, 2015
  • Duration: 1 Hour
  • Session: 11:00 AM EST
    View your Time Zone start time

    Register Now
Abstract:
Mitigation of bioreactor contamination risk is complex. People can be lulled into a sense of security that serum-free media eliminates that risk. However presence of contaminants such as mycoplasma can be devastating, leading to extensive investigation and downtime. After attending this webinar you will be able to better scrutinize your process, identify gaps and propose solutions relating to bioreactor contamination mitigation. You will also learn what questions to ask your vendor to make the optimal filter selection and you will be able to conduct an objective comparison of filter claims vs. performance.

Industrial Microbiology

The Whole Blood Assay: Detection of Broad Spectrum of Pyrogens and Examples of Medical Device Testing

  • Presenter: Thomas Hartung, MD PhD, is Professor of Toxicology Pharmacology, Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health, Baltimore, and University of Konstanz, Germany; he also is Director of their Centers for Alternatives to Animal Testing (CAAT)
  • Date: Thursday, April 9, 2015, 15:00 PM CET
  • Duration: 1 Hour

Register Now
Abstract:
Pyrogens in pharmaceuticals, medical devices, biotherapeutics and cosmetics can cause fevers in humans and are potentially life-threatening. Yet standard pyrogen detection methods have drawbacks. The Limulus Amoebocyte Lysate (LAL) test only identifies endotoxins, while the rabbit pyrogen test (RPT) endangers animals. Fortunately, the MAT (Monocyte-Activation Tests) alternative covers a much broader range of pyrogens and is completely animal-free. In our insightful webinar you will get a closer look at the whole blood assay, non-endotoxin pyrogens detection, and pyrogen testing in medical devices.

Life Science Research

Off-the-Shelf Immunoassay Kits: What’s Really Inside That Box?

  • Presenters: John Allinson, Head of Biomarker Strategy at Drug Development Services LGC and Sonali Nayak, Technical Services Manager, Bioscience Division, Merck Millipore
  • Date: Thursday, April 16, 2015
  • Time: 1PM EDT
  • Duration: 1 hour

Register Now
Abstract:
You’ve just purchased a multiplex assay to quantify your protein analytes of interest and want to validate the panel for your research or clinical study. Due to the complexity introduced by the nature of multiplexed vs. single-plex assays, what criteria do you need to consider to ensure that your data are precise, reproducible, and accurate? Attend this webinar to hear John Allinson (LGC), renowned clinical biomarker assay expert, discuss the power of multiplex assays employing the Luminex xMAP® technology. Using MILLIPLEX® MAP multiplexed assays as an example, Mr. Allinson will address potential challenges and solutions to be considered when validating off-the-shelf multiplexed biomarker assays for clinical and translational research. You will learn key factors to consider when developing and validating your assay method, including reference to standard material, sample stability and collection integrity, validation and QC samples, and the validity of reference standards.